Sir,
A 30-year-old woman presented to us with fever, chills, and rigor and lethargy of three days duration. She had a history of polyarthritis and fatigue of three years duration. Two months earlier, she had been started on hydroxychloroquine. On examination, she was febrile, drowsy, had neck stiffness, papilloedema, and ocular flutter (OF). [Video 1] Optic nerve sheath diameters were elevated (0.65 mm) bilaterally, suggestive of raised intracranial pressure. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) brain with contrast was normal. Her blood results showed Leukopenia (3,000/uL), thrombocytopenia 147 k/Ul, and normal C3, C4 levels. Cerebrospinal Fluid (CSF) showed mild pleocytosis (total count of 28 cells [100% lymphocytes]) and high protein 226 mg/dl with normal glucose levels and an elevated opening pressure of 27 cms H20. A Biofire meningoencephalitis panel was negative [E. coli, H. influenzae, L. monocytogenes, N. meningitidis, S.agalactiae, S. pneumoniae, CMV, Enterovirus, HSV 1 and 2, HHV-6, human parechovirus, Varicella zoster virus, and C.neoformans/gattii]. Work up for Dengue, Malaria, Scrub Typhus, Leptospira, HIV, and Lyme disease were negative. Rheumatoid Factor (30 IU/mL) and Antinuclear Antibody (ANA) were positive. ANA profile showed very strong bands for nRNP/SM and Ro-52. Anti CCP [<7 U/mL], anti-Beta 2 glycoprotein IGG, IGM, Lupus anticoagulant-DRVVT, Anti-Ds DNA and anti-Cardiolipin antibodies (IgG and IgM) reports were negative. Autoimmune neuronal antibodies [GABA B receptor, Glutamate receptor antibody NMDA (Anti NR-1), Contactin-associated protein 2 (CASPR2), Leucine-rich glioma inactivated protein 1 (LGI1), AMPA 1, and AMPA 2 antibodies], MOG IgG, and NMO IgG were negative. Paraneoplastic antibody panel [ANNA-1, 2, 3, PCA 1, 2, Tr, AGNA-1, Amphiphysin, CRMP-5, Ma/Ta] were also negative. She was started on Inj Dexamethasone 4 mg IV BD × 5 days and made an uneventful recovery within a week. Subsequently, Mycophenolate mofetil 1 gm/day was added to hydroxychloroquine at discharge.
Our patient fulfilled the criteria for undifferentiated connective tissue disease (UCTD) [Arthralgia, arthritis, a positive ANA result, and a disease duration of three years]. She presented with a short-lasting steroid-responsive encephalitis, specifically a rhombencephalitis with OF. [Table 1]. Rhombencephalitis refers to inflammatory conditions affecting the hindbrain (brainstem and cerebellum) and is associated with a wide variety of etiologies including infections (predominantly Listeriosis), autoimmune disease, and paraneoplastic syndromes. The detection of OF in our patient localized the condition to the ponto-cerebellar area. We present an unusual case UCTD with OF.
Table 1.
Idiopathic (Isolated OF) | Demyelination |
Paraneoplastic | Multiple sclerosis |
Lung | MOG antibody-associated demyelination (MOGAD)[1] |
Breast | |
Neuroblastoma | Metabolic |
Autoimmune | Hyperosmolar nonketotic coma |
NMDA | |
GAD 65 | Toxic |
Ganglioside anti-GQ1b antibodies | Serotonin syndrome[2] |
Cocaine | |
Ganglioside anti-GM2 antibodies | Cyclosporin A (CsA) therapy[3] |
Para/post-infectious | Toluene |
COVID-19 | Phenytoin |
HIV infection | Venlafaxine |
Amphetamine use | |
M.pneumonia | |
Cytomegalovirus | PCP (Phencyclidine) |
Scrub typhus | Miscellaneous |
Cerebral venous thrombosis.[4] | |
Traumatic brain injury[5] | |
Human herpesvirus 6 | |
Hepatitis C | |
Epstein-Barr virus | |
West Nile virus | Genetic causes; mutation in the potassium channel-related gene, KCTD7.[6] |
Lyme disease | |
Psittacosis | |
Salmonella | |
St Louis encephalitis | |
Rickettsia conorii. |
There are five major diffuse connective tissue diseases (DCTD) according to the conventional classification schema: Systemic lupus erythematosus; Systemic sclerosis (scleroderma); Myositis, Rheumatoid arthritis, and Sjögren's syndrome. Apart from these classic five, there are patients who meet the criteria for more than one DCTD, while others exhibit only some of the symptoms characteristic of different DCTD and cannot be definitively classified. These are also known as undifferentiated systemic rheumatic diseases (USRD). The concept of an entity called UCTD was first established in 1980.[7] Subsequently mixed connective tissue disease (MCTD), and other overlap syndromes were also described.
UCTD is a distinct clinical entity among USRD and its characteristics include: (a) clinical manifestation of at least one of the CTDs, (b) a positive ANA result, and (c) a disease duration of > one year.[8] Most patients with UCTD are young women who remain in the same category as UCTD throughout their lifetime, although a third can evolved into other well-defined CTDs. Like the DCTD, UCTD is associated with neurological complications such as myositis, inflammatory demyelinating disease, hypertrophic pachymeningitis, and reversible posterior leuko-encephalopathy, among others.[9] Meningitis, encephalitis, or OF have not yet been described with UCTD.
OF is an abnormal involuntary eye movement that consists of repetitive, irregular, bursts of horizontal saccades without an intersaccadic interval.[10] It results primarily from an abnormality in the saccadic generation pathway (the saccadic premotor neurons) that consists of the excitatory burst neurons (EBN), inhibitory burst neurons (IBN), and omnipause neurons (OPN). The OPN lies in the paramedian pontine reticular formation. It functions to silence the EBN and IBN in the inter-saccade interval and prevent unwanted movements in between. Increased GABAA receptor sensitivity in the Olivary-cerebellar-brainstem premotor neuron circuit may also be responsible. Thus, OF occurs when there is mistiming of neuronal activity between the cerebellar nuclei (vermis and fastigial nuclei) and the brainstem premotor neurons.[11] OF and opsoclonus share a similar pathophysiological mechanism. However, unlike opsoclonus, which can occur in any plane, OF is restricted to the horizontal plane. OF is associated with a wide variety of aetiologies including paraneoplastic syndromes, cerebellar/brainstem encephalitis, metabolic-toxic disturbance, demyelinating disease, viral infections, post-infectious syndrome, or as “isolated OF” when it cannot be attributed to any identifiable cause.[12] [Table 1] In our case, a transient autoimmune response directed against the OPN neurons due to UCTD, probably caused OF.
Thus, among patients who present with a meningo-encephalitis and OF, a DTCD or a USRD should be in the differential diagnosis. Such patients may respond to IV steroids. Long-term disease-modifying antirheumatic drugs will also need to be considered. Our case adds to the spectrum of neurological involvement in UCTD or USRD.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Video available on: www.annalsofian.org
REFERENCES
- 1.Breza M, Smyrni N, Koutsis G, Anagnostou E, Tzartos J, Velonakis G, et al. Ocular flutter as presenting manifestation of pediatric MOG antibody-associated demyelination: A case report. Mult Scler. 2019;25:122–5. doi: 10.1177/1352458518771872. [DOI] [PubMed] [Google Scholar]
- 2.Sim S-S, Sun J-T. Ocular flutter in the serotonin syndrome. N Engl J Med. 2016;375:e38. doi: 10.1056/NEJMicm1506066. [DOI] [PubMed] [Google Scholar]
- 3.Apsner R, Schulenburg A, Steinhoff N, Keil F, Janata K, Kalhs P, et al. Cyclosporin A-induced ocular flutter after marrow transplantation. Bone Marrow Transplant. 1997;20:255–6. doi: 10.1038/sj.bmt.1700809. [DOI] [PubMed] [Google Scholar]
- 4.Ploner CJ, Kupsch A. Ocular flutter in a patient with intracranial hypertension following cerebral venous thrombosis. Neurology. 2002;59:959. doi: 10.1212/wnl.59.6.959. [DOI] [PubMed] [Google Scholar]
- 5.Manta A, Ugradar S, Theodorou M. Ocular flutter after mild head trauma. J Neuro-Ophthalmology. 2018;38:476–8. doi: 10.1097/WNO.0000000000000683. [DOI] [PubMed] [Google Scholar]
- 6.Blumkin L, Kivity S, Lev D, Cohen S, Shomrat R, Lerman-Sagie T, et al. A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J Neurol. 2012;259:2590–8. doi: 10.1007/s00415-012-6545-z. [DOI] [PubMed] [Google Scholar]
- 7.Leroy EC, Maricq HR, Bashar Kahaleh M. Undifferentiated connective tissue syndromes. Arthritis Rheum. 1980;23:341–3. doi: 10.1002/art.1780230312. [DOI] [PubMed] [Google Scholar]
- 8.Mosca M, Tani C, Talarico R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases. Autoimmun Rev. 2011;10:256–8. doi: 10.1016/j.autrev.2010.09.013. [DOI] [PubMed] [Google Scholar]
- 9.Maramattom B. Facial myokymia due to a pontine inflammatory demyelinating disorder associated with Mixed connective tissue disorder [MCTD] Ann Indian Acad Neurol. 2020;23:355. doi: 10.4103/aian.AIAN_590_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Leigh J, Zee DS. 4th ed. New York, NY, USA: O. Oxford University Press; 2006. The Neurology of Eye Movements; pp. 475–558. 2015. [Google Scholar]
- 11.Optican LM, Pretegiani E. A GABAergic dysfunction in the olivary-cerebellar-brainstem network may cause eye oscillations and body tremor. II. Model simulations of saccadic eye oscillations. Front Neurol. 2017;8:372. doi: 10.3389/fneur.2017.00372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vavougios GD, Pelidou S-H, Mavromatis T, Mandras D, Ntoskas T. Spontaneous, isolated, and gaze-evoked ocular flutter: A rare case report. Clin Case Rep. 2020;8:955–7. doi: 10.1002/ccr3.2719. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.